Back to Journals » Hepatic Medicine: Evidence and Research » Volume 17 » default
Hepatic Medicine: Evidence and Research
- View all (212)
- Volume 18, 2026 (2)
- Volume 17, 2025 (15)
- Volume 16, 2024 (10)
- Volume 15, 2023 (22)
- Volume 14, 2022 (13)
- Volume 13, 2021 (16)
- Volume 12, 2020 (16)
- Volume 11, 2019 (16)
- Volume 10, 2018 (13)
- Volume 9, 2017 (10)
- Volume 8, 2016 (15)
- Volume 7, 2015 (8)
- Volume 6, 2014 (12)
- Volume 5, 2013 (7)
- Volume 4, 2012 (7)
- Volume 3, 2011 (14)
- Volume 2, 2010 (14)
- Volume 1, 2009 (2)
Archive: Volume 17, 2025
Literature Review on the Regulatory Effects of Hydrogen Sulfide in Non-Alcoholic Fatty Liver Disease (NAFLD)
Zhou S, Sun B, Xuan Z, Zhong G, Sun X, Yan J
Hepatic Medicine: Evidence and Research 2025, 17:209-218
Published Date: 27 December 2025
The Prevalence of Liver Enzyme Abnormalities Among Adult Patients with Non-Communicable Diseases in Rwanda: A Gender-Stratified Analysis
Tuyikurikire N, Tuyizere E, Imanishimwe J, Ahishakiye A, Asifiwe HJB, Rubayiza E, Gafirita J, Mapira HT, Nzitakera A, Wasihun AG, Musarurwa C
Hepatic Medicine: Evidence and Research 2025, 17:199-208
Published Date: 6 December 2025
Mapping the Intellectual Landscape: A 20-Year Bibliometric Analysis of Mechanisms in Metabolic Dysfunction-Associated Steatotic Liver Disease
Huang JW, Man NX, Wang HX, Ai XT, Wei DL, Dai YK
Hepatic Medicine: Evidence and Research 2025, 17:177-198
Published Date: 3 December 2025
Ischemia Reperfusion Injury Induced Systemic Inflammatory Response Following Interspecies Liver Transplantation
Rao JS, Rangarajan P, Shetty A, Steinhoff M, Tran A, Crane AT, Low WC, Steer CJ, Ramachandran S
Hepatic Medicine: Evidence and Research 2025, 17:161-176
Published Date: 1 December 2025
Aldose Reductase Mediated Mitophagy Promotes Epithelial-Mesenchymal Transition of Hepatocytes
Yan J, Zhao W, Wang H, Zhou L, Li X, Wang G
Hepatic Medicine: Evidence and Research 2025, 17:141-159
Published Date: 1 October 2025
Seroprevalence and Predictors of Hepatitis B and C Virus Infections Among Patients with Chronic Liver Diseases in Dodoma Region, Tanzania: A Cross-Sectional Study
Gyunda DJ, Yahaya JJ, Sindato EM, Meremo AJ
Hepatic Medicine: Evidence and Research 2025, 17:125-140
Published Date: 23 September 2025
Linking Brain and Immune Transcriptomes to Gut-Derived Metabolites in Hepatic Encephalopathy: An Explorative Integrative Multi-Omics Approach
Sepehrinezhad A, Shahbazi A
Hepatic Medicine: Evidence and Research 2025, 17:105-124
Published Date: 15 September 2025
Pharmacological Modulation of Liver and Spleen Stiffness in a Cirrhotic Rat Model
Elshaarawy O, Alquzi SHM, Piecha F, Rausch V, Mueller J, Mueller S
Hepatic Medicine: Evidence and Research 2025, 17:91-104
Published Date: 11 September 2025
MAFLD: A Comprehensive Review of the Link Between Metabolic Dysfunction and Cardiovascular Risk
Mostafa AM, Pan Z, Yu ML, Örmeci N, Fouad Y, Eslam M
Hepatic Medicine: Evidence and Research 2025, 17:75-90
Published Date: 19 August 2025
The Effect of Liv.52 DS in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Pilot, Randomized, Double-Blind, Placebo-Controlled, Clinical Study
Jalihal U, Nanda RA, Katariya K, Ramanathan B, Kumawat R
Hepatic Medicine: Evidence and Research 2025, 17:61-73
Published Date: 1 August 2025
Historical and Emerging Trends in Hepatitis B Virus Integration: A Bibliometric Visual Analysis
Liu J, Xu L, Ma X, Bi Y, Xin Y
Hepatic Medicine: Evidence and Research 2025, 17:39-59
Published Date: 18 July 2025
Performance of APRI and FIB-4 Scores Compared to FibroScan: A Cross-Sectional Study in a Black Sub-Saharan African Population
Nsumbu JB, Makulo JR, Mutombo Tshiswaka T, Kisoka Lusunsi C, Nlombi Mbendi C
Hepatic Medicine: Evidence and Research 2025, 17:27-37
Published Date: 15 July 2025
Identification of Ferroptosis-Related Genes in MAFLD/MASH and HQHF Validation [Corrigendum]
Liu S, Zhang L, Xu J, Zhao Q, Shang D, Liu X, Zhang Q, Liu M, Zhao W
Hepatic Medicine: Evidence and Research 2025, 17:25-26
Published Date: 18 June 2025
Identification of Ferroptosis -Related Genes in MAFLD/MASH and HQHF Validation
Liu S, Zhang L, Xu J, Zhao Q, Shang D, Liu X, Zhang Q, Liu M, Zhao W
Hepatic Medicine: Evidence and Research 2025, 17:13-24
Published Date: 2 May 2025
Development of a Nomogram for Prognostic Prediction of Large Hepatocellular Carcinoma With HBV After TACE Combined Conversion Therapy
Xu W, Ding X, Xu Y, Zhang Y, Xu H, Guo L, Li L
Hepatic Medicine: Evidence and Research 2025, 17:1-12
Published Date: 7 April 2025